February 20, 2024

ARTBIO

AlphaGen Therapeutics and ARTBIO Announce Exclusive Strategic Collaboration for the Development and Commercialization of AV001 in Greater China and on ARTBIO’s 212Pb AlphaDirect™ Technology

February 07, 2024

Septerna

Septerna Appoints Industry Veterans Bernard Coulie, M.D., Ph.D., and Shalini Sharp to its Board of Directors

February 04, 2024

Pliant Therapeutics

Pliant Therapeutics Announces Positive Safety and Exploratory Efficacy Data from the INTEGRIS-PSC Phase 2a Trial of Bexotegrast 320 mg in Patients with Primary Sclerosing Cholangitis and Suspected Liver Fibrosis

January 26, 2024

Flare Therapeutics

Flare Therapeutics Presents Fx-909 Phase 1 Dose Escalation and Expansion Clinical Trial Design at the 2024 ASCO Genitourinary Cancers Symposium

January 24, 2024

Synnovation Therapeutics

Synnovation Therapeutics Launches with $102 Million to Advance Clinical-Stage Pipeline of Precision Therapies Targeting Highly Validated Disease Pathways

Load More

Sign up for weekly portfolio news.